Literature DB >> 14051187

EPINEPHRINE IN CARDIAC RESUSCITATION.

J W PEARSON, J S REDDING.   

Abstract

Entities:  

Keywords:  ASPHYXIA; CEREBRAL ANOXIA; DOGS; DROWNING; EPINEPHRINE; EXPERIMENTAL LAB STUDY; HEART ARREST; HEART MASSAGE; INFANT; INJECTIONS; INTUBATION, INTRATRACHEAL; OXYGEN INHALATION THERAPY; RESUSCITATION; SHOCK THERAPY, ELECTRIC; VENTRICULAR FIBRILLATION

Mesh:

Substances:

Year:  1963        PMID: 14051187     DOI: 10.1016/0002-8703(63)90036-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  7 in total

1.  The 1998 European Resuscitation Council guidelines for adult advanced life support. Advanced Life Support Working Group of the European Resuscitation Council.

Authors: 
Journal:  BMJ       Date:  1998-06-20

Review 2.  Use of inotropes and vasopressor agents in critically ill patients.

Authors:  Mansoor N Bangash; Ming-Li Kong; Rupert M Pearse
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 3.  Pressor agents.

Authors:  N T Smith
Journal:  Calif Med       Date:  1967-07

4.  [Intensive therapy and prognosis of acuteheart arrest].

Authors:  H P Schuster; P Baum; P Schölmerich
Journal:  Klin Wochenschr       Date:  1969-01-01

5.  THE CHEMOTHERAPY OF CARDIAC ARREST.

Authors:  M MINUCK
Journal:  Can Med Assoc J       Date:  1965-01-02       Impact factor: 8.262

6.  Esmolol for cardioprotection during resuscitation with adrenaline in an ischaemic porcine cardiac arrest model.

Authors:  Hilde Karlsen; Harald Arne Bergan; Per Steinar Halvorsen; Kjetil Sunde; Eirik Qvigstad; Geir Øystein Andersen; Jan Frederik Bugge; Theresa Mariero Olasveengen
Journal:  Intensive Care Med Exp       Date:  2019-12-04

Review 7.  Effects of epinephrine for out-of-hospital cardiac arrest: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Lu Huan; Fei Qin; Yin Wu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.